$RPDL
Rapid Line Inc.

2023 Q1 Form 10-K Financial Statement

#000168316823002515 Filed on April 18, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2023 2022 Q1
Revenue $6.300K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $28.49K
YoY Change 3802.74%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $28.49K $731.00
YoY Change 3802.74%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$22.19K
YoY Change 2939.73%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$22.19K -$22.19K -$732.00
YoY Change 2931.42% 2939.73%
Net Earnings / Revenue -352.22%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 3.568M shares 2.878M shares 2.500M shares
Diluted Shares Outstanding 2.878M shares 2.500M shares

Balance Sheet

Concept 2023 Q1 2023 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $23.07K $51.00
Short-Term Investments
Other Short-Term Assets $24.76K
YoY Change 49420.0%
Inventory
Prepaid Expenses $1.687K $0.00
Receivables
Other Receivables
Total Short-Term Assets $24.76K $24.76K $51.00
YoY Change 48441.18% 49420.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $32.45K $40.65K
YoY Change -20.16%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $32.45K $32.45K $40.65K
YoY Change -20.16% -20.17%
TOTAL ASSETS
Total Short-Term Assets $24.76K $24.76K $51.00
Total Long-Term Assets $32.45K $32.45K $40.65K
Total Assets $57.21K $57.21K $40.70K
YoY Change 40.56% 40.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $4.280K
YoY Change 2277.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.280K $4.280K $180.00
YoY Change 2277.78% 2277.78%
LONG-TERM LIABILITIES
Long-Term Debt $54.24K
YoY Change 32.29%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $54.24K $54.24K $41.00K
YoY Change 32.3% 32.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.280K $4.280K $180.00
Total Long-Term Liabilities $54.24K $54.24K $41.00K
Total Liabilities $58.52K $58.52K $41.18K
YoY Change 42.12% 42.11%
SHAREHOLDERS EQUITY
Retained Earnings -$22.92K -$732.00
YoY Change 3031.28%
Common Stock $357.00 $250.00
YoY Change 42.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.316K -$1.320K -$481.00
YoY Change
Total Liabilities & Shareholders Equity $57.21K $57.21K $40.70K
YoY Change 40.56% 40.57%

Cashflow Statement

Concept 2023 Q1 2023 2022 Q1
OPERATING ACTIVITIES
Net Income -$22.19K -$22.19K -$732.00
YoY Change 2931.42% 2939.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$11.58K -$551.00
YoY Change 2005.64%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$40.65K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $21.36K
YoY Change 8442.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $34.60K $41.25K
YoY Change -16.12%
NET CHANGE
Cash From Operating Activities -$11.58K -$551.00
Cash From Investing Activities $0.00 -$40.65K
Cash From Financing Activities $34.60K $41.25K
Net Change In Cash $23.02K $51.00
YoY Change 45936.0%
FREE CASH FLOW
Cash From Operating Activities -$11.58K -$551.00
Capital Expenditures $0.00
Free Cash Flow -$11.58K
YoY Change -71.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001910975
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 NONE Proceeds From Repayment Of Promissory Note
ProceedsFromRepaymentOfPromissoryNote
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-263739
CY2023 dei Entity Registrant Name
EntityRegistrantName
RAPID LINE INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1646802
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Gieldowa 4A,
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Warsaw
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01-211
CY2023 dei Entity Address Country
EntityAddressCountry
PL
CY2023 dei Country Region
CountryRegion
48
CY2023 dei City Area Code
CityAreaCode
222
CY2023 dei Local Phone Number
LocalPhoneNumber
196622
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3567750 shares
CY2023 dei Auditor Name
AuditorName
Gries & Associates, LLC
CY2023 dei Auditor Location
AuditorLocation
Denver, Colorado
CY2023 dei Auditor Firm
AuditorFirmId
6778
CY2023Q1 us-gaap Cash
Cash
23069 usd
CY2022Q1 us-gaap Cash
Cash
51 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1687 usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
24756 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
51 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
41000 usd
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
41000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8548 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
352 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32452 usd
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40648 usd
CY2023Q1 us-gaap Assets
Assets
57208 usd
CY2022Q1 us-gaap Assets
Assets
40699 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
4280 usd
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
180 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4280 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
180 usd
CY2023Q1 NONE Director Loan
DirectorLoan
13244 usd
CY2022Q1 NONE Director Loan
DirectorLoan
0 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
41000 usd
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
41000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
54244 usd
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
41000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
58524 usd
CY2022Q1 us-gaap Liabilities
Liabilities
41180 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3567750 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3567750 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2500000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2500000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
357 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
250 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21248 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22921 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-731 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1316 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-481 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57208 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40699 usd
CY2023 us-gaap Revenues
Revenues
6300 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28490 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
731 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
28490 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
731 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-22190 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-731 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-22190 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-731 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2877942 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2877942 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2500000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2500000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
250 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-731 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-481 usd
CY2023 NONE Stock Issued During Period Value New Issues1
StockIssuedDuringPeriodValueNewIssues1
3350 usd
CY2023 NONE Stock Issued During Period Value New Issues2
StockIssuedDuringPeriodValueNewIssues2
12505 usd
CY2023 NONE Stock Issued During Period Value New Issues3
StockIssuedDuringPeriodValueNewIssues3
21276 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-22190 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1316 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-22190 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-731 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
4100 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
180 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
8196 usd
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1687 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11581 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-551 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
40648 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40648 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21355 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
250 usd
CY2022Q1 NONE Proceeds From Repayment Of Promissory Note
ProceedsFromRepaymentOfPromissoryNote
41000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
13244 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34599 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41250 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
23018 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
51 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23069 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
154 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22921 usd
CY2023 us-gaap Revenues
Revenues
6300 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zfYU2pIEUHYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86C_z9O1HfZyYJg9">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_z2CKecPIFXdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Risks and Uncertainties</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time but is anticipated to have a material adverse impact on our business, financial condition and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2500000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
250 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2667500 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2667500 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3292750 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3292750 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3567750 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3567750 shares
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4660 usd
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
154 usd
CY2023Q1 NONE Deferred Related Party Accruals
DeferredRelatedPartyAccruals
0 usd
CY2022Q1 NONE Deferred Related Party Accruals
DeferredRelatedPartyAccruals
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4660 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8548 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
352 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32452 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
40648 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4813 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4813 usd
CY2022Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-154 usd
CY2023 NONE Related Party Accruals
RelatedPartyAccruals
0 usd
CY2022Q1 NONE Related Party Accruals
RelatedPartyAccruals
0 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
4813 usd
CY2022Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
154 usd

Files In Submission

Name View Source Status
0001683168-23-002515-index-headers.html Edgar Link pending
0001683168-23-002515-index.html Edgar Link pending
0001683168-23-002515.txt Edgar Link pending
0001683168-23-002515-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
none-20230131.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20230131_cal.xml Edgar Link unprocessable
none-20230131_def.xml Edgar Link unprocessable
none-20230131_lab.xml Edgar Link unprocessable
none-20230131_pre.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rapidline_ex3101.htm Edgar Link pending
rapidline_ex3201.htm Edgar Link pending
rapidline_i10k-013123.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
rapidline_i10k-013123_htm.xml Edgar Link completed